Pantherx® Rare Selected By Insmed To Dispense BRINSUPRITM (Brensocatib) For The Treatment Of Non-Cystic Fibrosis Bronchiectasis

(MENAFN- PR Newswire)

PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- PANTHERx® Rare Pharmacy, a leader in rare disease product patient access and support services in the United States, announced that it was selected by Insmed as part of the network of specialty pharmacies to dispense BRINSUPRITM (brensocatib), a once daily oral medication to treat non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older.^{1 2}

"The PANTHERx team is pleased to be chosen by Insmed to dispense BRINSUPRITM, the first and only FDA-approved treatment for NCFB," said Bansi Nagji, CEO, PANTHERx® Rare Pharmacy.

About PANTHERx Rare
PANTHERx Rare is a specialty pharmacy exclusively focused on rare and orphan diseases, distributing several orphan products, and providing access and support services to those needing them most. Known as The Rare Disease Pharmacy®, PANTHERx transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to people living with rare and devastating conditions.

PANTHERx is a dual-accredited specialty pharmacy, holding distinctions in rare disease including the Accreditation Commission for Health Care (ACHC) Distinction in Orphan Drugs and Utilization Review Accreditation Commission (URAC) Rare Disease Center of Excellence. As a pharmacy focused on patient satisfaction, PANTHERx is the eight-time winner of the prestigious MMIT Patient Choice Award, including the 2025 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania and is licensed in all 50 states and U.S. territories.

CONTACT:
For more information, please email [email protected] or visit .

1	BRINSUPRITM (brensocatib) Prescribing Information . Insmed, 2025.
2	Macfarlane L, Kumar K, Scoones T, et al. "Diagnosis and management of non-cystic fibrosis bronchiectasis," Clinical Medicine. 2021;21(6):e571-7. doi:

SOURCE PANTHERx Rare Pharmacy

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN13082025003732001241ID1109923266